Nicotinamide Mononucleotide (NMN) Market Growth Analysis, Market Dynamics 2024-2030

The Global Nicotinamide Mononucleotide (NMN) Market, valued at US$ 360.37 million in 2023, is projected to reach US$ 762.61 million by 2030, experiencing a robust CAGR of 10.9% during the forecast period 2024-2030.


Report Sample includes:

- Table of Contents

- List of Tables & Figures

- Charts

- Research Methodology


Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/169/nicotinamide-mononucleotide-nmn



North American Market:


  • The North American market for Nicotinamide Mononucleotide (NMN) consumption is estimated to grow from $59.88 million in 2023 to $120.04 million by 2030, with a notable CAGR of 9.73% during the forecast period of 2024 through 2030.

China Market:


  • The China market for Nicotinamide Mononucleotide (NMN) consumption is anticipated to increase from $231.27 million in 2023 to $504.37 million by 2030, demonstrating a robust CAGR of 11.47% during the forecast period of 2024 through 2030.

Key Manufacturers:


  • GeneHarbor: A major player in the Nicotinamide Mononucleotide (NMN) market, GeneHarbor significantly contributes to the industry's growth and technological advancements.
  • Herbalmax: As a key manufacturer, Herbalmax plays a crucial role in shaping the global NMN market.
  • Genex Formulas: Genex Formulas adds to the market's dynamics and influences trends with its NMN products.
  • Mirailab Bioscience: A notable manufacturer, Mirailab Bioscience contributes to the diversity and innovation within the NMN market.
  • Maac10 Formulas: With its expertise, Maac10 Formulas adds to the market's product offerings and technological advancements.
  • EffePharm: EffePharm is a significant player, contributing to the global market with its presence and market share.
  • Bontac: Bontac is a notable player, contributing to the market dynamics with its NMN products.
  • CELFULL: With its global presence, CELFULL significantly influences the Nicotinamide Mononucleotide market.
  • Kingdomway: Kingdomway is a significant player, contributing to the market's growth and technological advancements.
  • In 2023, the top three vendors in the Nicotinamide Mononucleotide market collectively accounted for approximately 74.43% of the total revenue, indicating a competitive landscape with key players dominating the market.


Nicotinamide mononucleotide (NMN) is a molecule that has gained attention in recent years for its potential health benefits.


  • NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), a coenzyme that plays a crucial role in energy metabolism, DNA repair, and cellular aging.
  • Studies in animals have shown that supplementing with NMN can increase NAD+ levels and improve markers of health and longevity.
  • NMN has been studied for its potential benefits in various conditions, including age-related decline, cardiovascular disease, and neurodegenerative disorders.
  • NMN is available as a dietary supplement in some countries, including the United States, but its safety and effectiveness in humans is still being studied.
  • Some researchers have raised concerns about the potential side effects of NMN supplementation, such as increased risk of cancer or liver toxicity.


This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN).


The Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.


For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.


The report will help the Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company


  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • Mirailab Bioscience
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway

Segment by Type


  • Content ‚Č•98%
  • Content <98%

Segment by Application


  • Health Care Products
  • Cosmetics
  • Others

Production & Consumption by Region


  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

key trends shaping the nicotinamide mononucleotide (NMN) market:


Growing demand for anti-aging products - Increase in life expectancy and rising consumer interest in active aging and longevity is driving demand for NMN as a key ingredient in anti-aging supplements and cosmetics.

Advancements in production technologies - Biosynthetic manufacture of high-purity NMN is gaining traction over extraction from natural sources, helping improve yields, reduce costs and enable large-scale production.

Expanding applications in healthcare - Positive research outcomes demonstrating NMN benefits in treating obesity, neurodegenerative disorders, fertility, diabetes etc. are widening its application scope as a bioactive nutrient.

Strategic partnerships and M&A activity - Collaboration and consolidation among nutrition companies, research pioneers and NMN manufacturers is occurring to accelerate R&D and commercialization.

Favorable regulatory support - Regulatory approvals for NMN use in supplements and pharmaceuticals, such as GRAS status in the U.S., are encouraging product development and mainstream adoption.

Distribution expansion - Rising retail presence through specialty stores, pharmacies, online channels aided by marketing efforts to increase consumer awareness about NMN products.


Market Dynamics:


  • The NMN market is driven by factors such as increasing awareness about health and wellness, anti-aging properties, and growing research on the potential health benefits of NMN.
  • Regional variations, consumer preferences, and regulatory frameworks will shape the market's trajectory during the forecast period.

Get the Complete Report & TOC at https://www.intelmarketresearch.com/chemicals-and-materials/169/nicotinamide-mononucleotide-nmn

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

Email: help@intelmarketresearch.com


Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports